Abstract:Abstract Background : Cancer stem cells are the important factors that lead to drug resistance, recurrence and metastasis of tumor. Immunotherapy has become the first-line treatment for advanced Hepatocellular Carcinoma(HCC), however, the importance of cancer stem cells in the immunotherapy of HCC has not been well elucidated. Methods : We identified a subset of cells with stemness characteristics by analyzing single-cell sequencing data from tumor tissue samples from 10 patients with HCC. We screened these cell populations for overexpressed genes, defined as cancer stem cell-related genes. Subsequently, we comprehensively analyzed the bulk RNA sequencing data of 365 HCC patients to construct a cancer stem cell-related genes prognostic signature(CSGPS). According to the CSGPS, 365 patients with HCC were divided into high-risk and low-risk groups. Multiple independent external cohorts were used to assess the predictive value of the CSGPS. T cell receptor (TCR) richness, Cancer Testicular Antigens (CTA) scores, Microsatellite instability (MSI), expression of immune checkpoint-related genes, and Tumour Immune Dysfunction and Exclusion (TIDE) scores were used to assess the intensity of response to immunotherapy in different risk groups. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to verify the mRNA expression levels of cancer stem cell-related genes in HCC tissues. Results: CSGPS is an independent risk factor for the prognosis of HCC patients, and it is significantly superior to other clinical features in predicting the prognosis and immunotherapy response of HCC patients. Multiple independent external cohorts validated the validity and robustness of the CSGPS. Immune infiltration analysis showed that cancer stem cell-related genes can recruit immune cells with immunosuppressive functions, such as Treg, macrophages infiltration. The CSGPS was correlated with the TCR, CTA score, MSI score, expression of immune checkpoint-related genes, and TIDE score. Patients in the high-risk group identified by the CSGPS may respond more strongly to immunotherapy and be more suitable to immunotherapy. The results of qRT-PCR confirmed that 8 cancer stem cell-related genes were overexpressed in HCC tissues. Conclusion: Cancer stem cell-related genes are overexpressed in HCC and contribute to the formation of an immunosuppressive microenvironment. Targeting cancer stem cells may become a new target for immunotherapy of HCC. Our novel prognostic signatureof cancer stem cell-related genes can effectively predict the prognosis and immunotherapy response of HCC patients. In the future, the prognostic signature will help clinicians to select the appropriate population for immunotherapy and improve the response rate of immunotherapy.

Autophagy Contributes to the Survival of CD133+ Liver Cancer Stem Cells in the Hypoxic and Nutrient-Deprived Tumor Microenvironment

Effect of GLUT1 Inhibition and Autophagy Modulation on the Growth and Migration of Laryngeal Carcinoma Stem Cells under Hypoxic and Low-Glucose Conditions

Egr-1 Promotes Hypoxia-Induced Autophagy to Enhance Chemo-Resistance of Hepatocellular Carcinoma Cells.

CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival.

Cancer-associated Fibroblasts Endow Stem-Like Qualities to Liver Cancer Cells by Modulating Autophagy

CD133+ Liver Cancer Stem Cells Resist Interferon-Gamma-induced Autophagy

Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma.

Resistance of Glioma Cells to Nutrient-Deprived Microenvironment Can Be Enhanced by CD133-mediated Autophagy.

Hypoxia-Induced Autophagy Contributes To The Chemoresistance Of Hepatocellular Carcinoma Cells

Cd133 Silencing Inhibits Sternness Properties And Enhances Chemoradiosensitivity In Cd133-Positive Liver Cancer Stern Cells

Lipopolysaccharide Supports Maintaining the Stemness of CD133(+) Hepatoma Cells Through Activation of the NF-κB/HIF-1α Pathway.

Low Glucose Promotes CD133mAb-elicited Cell Death Via Inhibition of Autophagy in Hepatocarcinoma Cells

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin

Targeting Autophagy Potentiates Chemotherapy-Induced Apoptosis and Proliferation Inhibition in Hepatocarcinoma Cells.

Development of an Autophagy-Based and Stemness-Correlated Prognostic Model for Hepatocellular Carcinoma Using Bulk and Single-Cell RNA-Sequencing

Emerging Role Of Autophagy During Ischemia-Hypoxia And Reperfusion In Hepatocellular Carcinoma

Autophagic LC3B Overexpression Correlates with Malignant Progression and Predicts a Poor Prognosis in Hepatocellular Carcinoma.

Hypoxia induces stemness properties in hepatocellular carcinoma cells

ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms

Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma.

Cancer Stem Cells Remodel the Tumor Microenvironment and Influence Immunotherapy Response in Hepatocellular Carcinoma